Helped by base effect (from the pandemic), Atul's income from operations by a little enthusing 63.5% to Rs 1080.20 crs from just Rs 660.56 crs in the same quarter a year ago; though quarter on quarter income from operations slid 3.2%. Performance and other chemicals business accounted for most of the swell for its sales advanced by a blistering...

Atul Ltd. has an average target of 8754.33 from 3 brokers.

Atul Ltd.

23 Oct 2020

5681.00

-0.60%

Atul

Buy: Atul Ltd.

Sharekhan

Atul Limited (Atul) reported consolidated revenue of Rs. 1,002 crore (down 4.2%; up 51.7% q-o-q), which was 7.9% above our estimate of Rs. 929 crore. Revenue beat was on the account of betterthan-expected revenue from life science chemicals segment at Rs. 348 crore (up 5.3% y-o-y; up 28.3% q-o-q), while revenue from performance and other chemicals segment was largely in-line at Rs. 690 crore (down 7.7% y-o-y; up 64% q-o-q). The sharp sequential improvement in revenue can be attributed to higher demand from key user industries in the domestic market as economic activities recovered sharply post unlockdown by the government. EBITDA margin came in at 26.1% (up 460 bps y-o-y; up 204 bps q-o-q), which was also above our estimate of 25% due to higherthan-expected margin in the performance and other chemicals segment (EBIT margin up 411 bps y-o-y to 23.1%). The improvement in EBITDA margin was on account of better operating leverage...

Atul Ltd. has an average target of 8754.33 from 3 brokers.

Atul Ltd.

23 Oct 2020

5681.00

-0.60%

Atul

Accumulate: Atul Ltd.

Recommendation Target

Dolat Capital

Atul Ltd's result was yet another surprise on the margin front, with sales too slowly reverting to pre-covid levels. Sales came in above our estimate at Rs 10.02bn (D.est: Rs 9.07) down by 4.2% YoY. EBITDA (D.est: Rs 2.06 bn) grew by 16.4% YoY to Rs 2.61bn, with a strong EBITDA margin of 26.1%, an increase of 460 bps YoY. The company has controlled its other expenses and power and fuel costs,...

Atul Ltd. is trading above its 50 day SMA of 5677.4

Atul Ltd.

25 Aug 2020

5681.00

-0.60%

Atul

Buy: Atul Ltd.

Target

CD Equisearch

Scarcely unscathed by the horrendous pandemic which triggered countrywide lockdown and forced suspension of Atul's manufacturing plants, beside others, its income from operations plunged by a little pleasing 36.5% to Rs 660.56 crs in the first quarter compared to Rs 1040.55 crs in the same quarter a year ago. Due to its far lesser reliance on essentials when compared to life science chemicals, performance and other chemicals barely managed to evade the brunt of the pandemic for its revenues slid by a little gratifying, though barely sustainable, 42.6%,...

Atul Ltd. has lost -26.78% in the last 6 Months

Is Atul Ltd. worth buying?

178 Votes:

Buy 75.28%

Sell 14.04%

Hold 10.67%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf